1ont
From Proteopedia
(Difference between revisions)
Line 6: | Line 6: | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1ont FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1ont OCA], [http://www.rcsb.org/pdb/explore.do?structureId=1ont RCSB], [http://www.ebi.ac.uk/pdbsum/1ont PDBsum]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1ont FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1ont OCA], [http://www.rcsb.org/pdb/explore.do?structureId=1ont RCSB], [http://www.ebi.ac.uk/pdbsum/1ont PDBsum]</span></td></tr> | ||
</table> | </table> | ||
+ | == Function == | ||
+ | [[http://www.uniprot.org/uniprot/CXKT_CONTU CXKT_CONTU]] Conantokins inhibit N-methyl-D-aspartate (NMDA) receptors. This toxin inhibits both NR2A and NR2B subunits of N-methyl-D-aspartate (NMDA) receptor-mediated calcium influx in central nervous system neurons. Induces sleep-like symptoms in young mice and hyperactivity in older mice.<ref>PMID:2165278</ref> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == |
Revision as of 14:21, 24 December 2014
NMDA RECEPTOR ANTAGONIST, CONANTOKIN-T, NMR, 17 STRUCTURES
|